(Verbatim from the Applicant): This application focuses on two novel autocrine/paracrine factors, which we have identified, that are produced by both murine and human OCLs: AXII, a stimulator of OCL formation, and OIP-2, an inhibitor of OCL formation. It is our hypothesis that these factors play a critical role in the physiologic regulation of OCL formation. Thus, understanding their mechanism of action will provide important insights into the control of osteoclastogenesis. To determine how these factors regulate OCL formation, we will pursue the following Specific Aims: (la) Determine the mechanism of action of AXII on OCI formation. AXII stimulates OCL formation through its capacity to induce production of high local levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) by CD4+ T-cells and marrow stromal cells. We will confirm that AXII can induce CFU-GM colony growth and test if AXII also acts directly on OCL precursors. In addition, we will assess the effects of AXII on RANK ligand and osteoprotegerin (OPG) expression. Since both T-cells and marrow stromal cells bind AXII and secrete GM-CSF, we will determine the relative contribution of T-cells by assessing OCL formation in marrow cultures depleted of total T-cells or CD4+ T-cells or adding CD4+ 1-cells to highly purified human OCL precursors treated with AXII. (lb) Identify and clone the AXII receptor we recently identified on marrow stromal cells. The receptor will be characterized in terms of its binding affinity and specificity for AXII and then will be cloned from a human marrow stromal cell library. (2a) Determine the mechanism responsible for the inhibitory action of OIP-2 on OCL formation. OIP-2 is identical to the enzyme legumain and appears to act directly on OCL precursors to inhibit OCL formation. We will confirm that OIP-2 inhibits OCL formation by highly purified OCL precursors, and test if OIP-2 affects RANKL, VDR, RANK or OPG expression in normal marrow cultures. (2b) Map the domains of OIP-2 responsible for its OCL inhibitory activity. We will confirm that the C-terminal domain of OIP-2 mediates its inhibitory effects on OCLs, assess if enzyme activity is required for OIP-2 activity, confirm that OCL precursors bind OIP-2, and clone and characterize the OIP-2 receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
7R01AG013625-15
Application #
6483297
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Carrington, Jill L
Project Start
1985-09-01
Project End
2006-03-31
Budget Start
2001-09-30
Budget End
2002-03-31
Support Year
15
Fiscal Year
2001
Total Cost
$240,398
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lu, Ganwei; Maeda, Hidefumi; Reddy, Sakamuri V et al. (2006) Cloning and characterization of the annexin II receptor on human marrow stromal cells. J Biol Chem 281:30542-50
Li, Fanghong; Chung, Hoyeon; Reddy, Sakamuri V et al. (2005) Annexin II stimulates RANKL expression through MAPK. J Bone Miner Res 20:1161-7
Roodman, G David (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655-64
Friedrichs, William E; Reddy, Sakamuri V; Bruder, Jan M et al. (2002) Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res 17:145-51
Choi, S J; Oba, Y; Gazitt, Y et al. (2001) Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest 108:1833-41
Roodman, G D (2001) Biology of osteoclast activation in cancer. J Clin Oncol 19:3562-71
Menaa, C; Barsony, J; Reddy, S V et al. (2000) 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease. J Bone Miner Res 15:228-36
Kurihara, N; Reddy, S V; Menaa, C et al. (2000) Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest 105:607-14
Menaa, C; Kurihara, N; Roodman, G D (2000) CFU-GM-derived cells form osteoclasts at a very high efficiency. Biochem Biophys Res Commun 267:943-6
Reddy, S V; Menaa, C; Singer, F R et al. (1999) Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone. Exp Hematol 27:1528-32

Showing the most recent 10 out of 15 publications